Clinical and genomic features of non-small cell lung cancer occurring in families

被引:1
|
作者
Miyabe, Shingo [1 ,2 ]
Ito, Shin [3 ]
Sato, Ikuro [4 ]
Abe, Jiro [1 ,5 ]
Tamai, Keiichi [3 ,5 ]
Mochizuki, Mai [3 ,5 ]
Fujimori, Haruna [5 ]
Yamaguchi, Kazunori
Shindo, Norihisa
Shima, Hiroshi [6 ]
Yamazaki, Tomoko [3 ]
Abue, Makoto [5 ]
Okada, Yoshinori [2 ]
Yasuda, Jun [3 ,7 ,8 ]
机构
[1] Miyagi Canc Ctr Hosp, Div Thorac Surg, Natori, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Japan
[3] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, Natori, Japan
[4] Miyagi Canc Ctr Hosp, Div Pathol, Natori, Japan
[5] Miyagi Canc Ctr Res Inst, Div Canc Stem Cell, Natori, Japan
[6] Miyagi Canc Ctr Res Inst, Div Canc Chemotherapy, Natori, Japan
[7] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, 47-1 Nodayama, Natori, Miyagi 9811293, Japan
[8] Saitama Med Univ, Dept Head & Neck Oncol, Int Med Ctr, Saitama, Japan
关键词
DHODH; exome; mutational signature; non-small cell lung cancer; tumor suppressor gene; GENETIC-VARIANTS; RISK; SUSCEPTIBILITY;
D O I
10.1111/1759-7714.14825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Exposure to environmental carcinogens, such as through smoking, is a major factor in the carcinogenesis of non-small cell lung cancer (NSCLC). However, genetic factors may also contribute.Methods To identify candidate tumor suppressor genes for NSCLC, we included 23 patients (10 related pairs and 3 individuals) with NSCLC who had other NSCLC-affected first-degree relatives in a local hospital. Exome analyses for both germline and somatic (NSCLC specimens) DNA were performed for 17 cases. Germline exome data of these 17 cases revealed that most of the short variants were identical to the variants in 14KJPN (a Japanese reference genome panel of more than 14 000 individuals) and only a nonsynonymous variant in the DHODH gene, p.A347T, was shared between a pair of NSCLC patients in the same family. This variant is a known pathogenic variant of the gene for Miller syndrome.Results Somatic genetic alterations in the exome data of our samples showed frequent mutations in the EGFR and TP53 genes. Principal component analysis of the patterns of 96 types of single nucleotide variants (SNVs) suggested the existence of unique mechanisms inducing somatic SNVs in each family. Delineation of mutational signatures of the somatic SNVs with deconstructSigs for the pair of germline pathogenic DHODH variant-positive cases showed that the mutational signatures of these cases included SBS3 (homologous recombination repair defect), SBS6, 15 (DNA mismatch repair), and SBS7 (ultraviolet exposure), suggesting that disordered pyrimidine production causes increased errors in DNA repair systems in these cases.Conclusion Our results suggest the importance of the detailed collection of data on environmental exposure along with genetic information on NSCLC patients to identify the unique combinations that cause lung tumorigenesis in a particular family.
引用
收藏
页码:940 / 952
页数:13
相关论文
共 50 条
  • [1] Clinical and genomic features of non-small-cell lung cancer occurring in families
    Yasuda, Jun
    Miyabe, Shingo
    Ito, Shin
    Sato, Ikuro
    Abe, Jiro
    Tamai, Keiichi
    Mochizuki, Mai
    Fujimori, Haruna
    Yamaguchi, Kazunori
    Shindo, Norihisa
    Shima, Hiroshi
    Yamazaki, Tomoko
    Abue, Makoto
    Okada, Yoshinori
    CANCER SCIENCE, 2024, 115 : 212 - 212
  • [2] Clinical and genomic features of high tumor mutation burden in patients with non-small cell lung cancer.
    Qiu, Yuan
    Yang, Haihong
    Chen, Hanzhang
    Deng, Qiuhua
    Liu, Liping
    Xiao, Dakai
    Shao, Di
    Li, Weiwei
    Jiang, Wenxi
    Zhu, Changbin
    Lin, Yongping
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Non-Small Cell Lung Cancer and Precision Medicine A Model for the Incorporation of Genomic Features Into Clinical Trial Design
    Pasche, Boris
    Grant, Stefan C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (19): : 1975 - 1976
  • [4] Clinical features of gefitinib-responders with non-small cell lung cancer
    Shenglin, M.
    Yaping, X.
    Qinghua, D.
    Xinmin, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer
    Liao, Rongxin
    Chen, Kehong
    Li, Jinjin
    He, Hengqiu
    Yi, Guangming
    Huang, Mingfeng
    Chen, Rongrong
    Shen, Lu
    Zhang, Xiaoyue
    Xu, Zaicheng
    Yang, Zhenzhou
    Peng, Yuan
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 814 - 831
  • [6] Genomic profiling for non-small cell lung cancer: Clinical relevance in staging and prognosis
    Bhattarai, Abhinav
    Shah, Sangam
    Abu Serhan, Hashem
    Sah, Ranjit
    Sah, Sanjit
    MEDICINE, 2023, 102 (47) : E36003
  • [7] Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
    Skakodub, Anna
    Walch, Henry
    Tringale, Kathryn R.
    Eichholz, Jordan
    Imber, Brandon S.
    Vasudevan, Harish N.
    Li, Bob T.
    Moss, Nelson S.
    Yu, Kenny Kwok Hei
    Mueller, Boris A.
    Powell, Simon
    Razavi, Pedram
    Yu, Helena A.
    Reis-Filho, Jorge S.
    Gomez, Daniel
    Schultz, Nikolaus
    Pike, Luke R. G.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [8] Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
    Anna Skakodub
    Henry Walch
    Kathryn R. Tringale
    Jordan Eichholz
    Brandon S. Imber
    Harish N. Vasudevan
    Bob T. Li
    Nelson S. Moss
    Kenny Kwok Hei Yu
    Boris A. Mueller
    Simon Powell
    Pedram Razavi
    Helena A. Yu
    Jorge S. Reis-Filho
    Daniel Gomez
    Nikolaus Schultz
    Luke R. G. Pike
    Nature Communications, 14 (1)
  • [9] Clinical Impact of Genomic Characterization in Induced Oligometastatic Non-small Cell Lung Cancer
    Fu, R.
    Xiong, Y. -Y.
    Li, F.
    Cai, M.
    Chen, R. -R.
    Li, H. -J.
    Wu, Y. -L.
    Zhong, W. -Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S303 - S304
  • [10] Genomic Landscape of Brazilian Non-Small Cell Lung Cancer
    Leal, L.
    De Marchi, P.
    Sussuchi Da Silva, L.
    Ferreira Da Silva, F.
    Campanha Novaes, L.
    Camargo Rodrigues, Y.
    Dos Santos, W.
    Albino Da Silva, E.
    Evangelista, A.
    Reis, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S422 - S422